IMRIS to Hold Second Quarter 2013 Results Conference Call

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WINNIPEG & MINNEAPOLIS, MN, Aug. 8, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)

Second Quarter 2013 Earnings
Release
August 13, 2013
Conference Call and WebcastAugust 13, 5:00 pm ET
Hosted by Jay Miller, President and Chief Executive Officer;
Kelly McNeill, Executive Vice President, Finance & CFO
Participant Numbers 1-480-629-9677 or 1-877-941-1467
Conference Call ID Number 4634223

A question and answer session for analysts and institutional investors will follow management's presentation.

A taped rebroadcast will be available to listeners until 12 a.m. on August 19, 2013. To access the rebroadcast from Canada please dial 1-416-640-1917 or 1-877-289-8525 and enter the passcode 4634223#. From the U.S., please dial 1-303-590-3030 or 1-800-406-7325 and enter the passcode 4634223#.

A live audio webcast will be available on the company's website at www.imris.com.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular, spinal and cerebrovascular markets and have been selected by 54 leading medical institutions around the world. For more information, visit www.imris.com.

SOURCE IMRIS Inc.



Hey, check out all the engineering jobs. Post your resume today!
MORE ON THIS TOPIC